Nursing care of the patient receiving high dose rate brachytherapy
- PMID: 1945963
Nursing care of the patient receiving high dose rate brachytherapy
Erratum in
- Oncol Nurs Forum 1993 Jan-Feb;20(1):11
Abstract
Over the past few decades, a significant increase in the incidence of lung cancer has occurred. In the majority of patients, the failure to cure lung cancer is related in part to an inability to obtain locoregional control of the disease. Remote afterloading high dose rate (HDR) brachytherapy has tremendous potential as a way to increase treatment to the primary site of lung cancer and to improve palliative management of recurrent disease when conventional treatments have failed. Because remote afterloading is used, the medical staff is not exposed to ionizing radiation, and since the duration of treatment is short, HDR brachytherapy is convenient for the patient and can be delivered on an outpatient basis. Fifty-two patients were treated endobronchially for carcinoma of the lung at Parkview Regional Oncology Center in Fort Wayne, IN, between May 1, 1988, and September 1, 1990. Nursing care during treatment and recovery of these patients will be discussed in this paper.
Similar articles
-
[Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].Strahlenther Onkol. 1995 Oct;171(10):554-9. Strahlenther Onkol. 1995. PMID: 8571174 German.
-
The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.Neoplasma. 2008;55(3):239-45. Neoplasma. 2008. PMID: 18348661
-
High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.Lung Cancer. 2008 Dec;62(3):326-33. doi: 10.1016/j.lungcan.2008.03.018. Epub 2008 May 14. Lung Cancer. 2008. PMID: 18482780
-
Trends in radiation therapy for the treatment of lung cancer.Nurs Clin North Am. 1992 Sep;27(3):643-51. Nurs Clin North Am. 1992. PMID: 1508737 Review.
-
High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.Laryngoscope. 2002 Aug;112(8 Pt 1):1366-71. doi: 10.1097/00005537-200208000-00008. Laryngoscope. 2002. PMID: 12172246 Review.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous